Apogee Therapeutics, Inc. Interest Receivable, Current
Apogee Therapeutics, Inc. (APGE) had Interest Receivable, Current of $9.59 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2026-08-10
- 2026-06-30: Interest Receivable, Current $9.59M.
- 2026-03-31: Interest Receivable, Current $7.28M.
- 2025-12-31: Interest Receivable, Current $5.96M.
- 2025-09-30: Interest Receivable, Current $4.48M.
| Period end | Interest Receivable, Current |
|---|---|
| 2026-06-30 | $9.59M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $7.28M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $5.96M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $4.48M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $4.14M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.01M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $4.70M 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.77M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $1.21M 10-K · filed 2025-03-03 |